ARZERRA - ofatumumab
Navigation: NDC > Supplier starting with: G > GLAXOSMITHKLINE LLC| Field | Value |
|---|---|
| NDC Code: | 0173-0821 |
| Proprietary Name: | ARZERRA |
| Suffix: | |
| Non-Proprietary Name: | ofatumumab |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 22-07-2011 |
| Category Name: | BLA |
| Application Number: | BLA125326 |
| Labeler: | GLAXOSMITHKLINE LLC |
| Substance Name: | OFATUMUMAB |
| Active Numerator Strength: | 20 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | CD20-directed Cytolytic Antibody [EPC] |
| DEA Schedule: |